Literature DB >> 7819051

Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.

J Adélaide1, G Monges, C Dérdérian, J F Seitz, D Birnbaum.   

Abstract

The human CCND1/PRAD1 gene, located in the 11q13 chromosomal region, encodes a cyclin D protein with potential oncogenic capacity and is involved in several human malignancies. The amplification and expression status of CCND1 was investigated in a series of oesophageal tumours. CCND1 is amplified in 54% and overexpressed in 63% of the tumours of the squamous cell type.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7819051      PMCID： PMC2033462          DOI： 10.1038/bjc.1995.13

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  46 in total

1.  D11S146 and BCL1 are physically linked but can be discriminated by their amplification status in human breast cancer.

Authors:  P Szepetowski; C Nguyen; D Perucca-Lostanlen; G F Carle; Y Tsujimoto; D Birnbaum; C Theillet; P Gaudray
Journal:  Genomics       Date:  1991-06       Impact factor: 5.736

2.  Characterization of a murine glyceraldehyde-3-phosphate dehydrogenase pseudogene.

Authors:  F Galland; M Stefanova; V Pirisi; D Birnbaum
Journal:  Biochimie       Date:  1990-10       Impact factor: 4.079

Review 3.  Cyclins and cancer.

Authors:  T Hunter; J Pines
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

4.  Localization of the HST/FGFK gene with regard to 11q13 chromosomal breakpoint and fragile site.

Authors:  A Hagemeijer; M Lafage; M G Mattei; J Simonetti; E Smit; O de Lapeyriere; D Birnbaum
Journal:  Genes Chromosomes Cancer       Date:  1991-05       Impact factor: 5.006

5.  D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.

Authors:  G A Lammie; V Fantl; R Smith; E Schuuring; S Brookes; R Michalides; C Dickson; A Arnold; G Peters
Journal:  Oncogene       Date:  1991-03       Impact factor: 9.867

6.  Human D-type cyclin.

Authors:  Y Xiong; T Connolly; B Futcher; D Beach
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

7.  A novel cyclin encoded by a bcl1-linked candidate oncogene.

Authors:  T Motokura; T Bloom; H G Kim; H Jüppner; J V Ruderman; H M Kronenberg; A Arnold
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

8.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.

Authors:  H Matsushime; M F Roussel; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

9.  High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.

Authors:  T Tsuda; E Tahara; G Kajiyama; H Sakamoto; M Terada; T Sugimura
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

10.  Characterization of a candidate bcl-1 gene.

Authors:  D A Withers; R C Harvey; J B Faust; O Melnyk; K Carey; T C Meeker
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272
View more
  18 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

2.  Clinical impact of predicting CCND1 amplification using plasma DNA in superficial esophageal squamous cell carcinoma.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Shoji Hirajima; Hiroki Takeshita; Atsushi Shiozaki; Hitoshi Fujiwara; Tsutomu Kawaguchi; Mahito Miyamae; Hirotaka Konishi; Takeshi Kubota; Kazuma Okamoto; Nobuaki Yagi; Eigo Otsuji
Journal:  Dig Dis Sci       Date:  2014-01-24       Impact factor: 3.199

3.  Ubiquitin-dependent proteolysis in G1/S phase control and its relationship with tumor susceptibility.

Authors:  J Alan Diehl; Bhaskar Ponugoti
Journal:  Genes Cancer       Date:  2010-07-01

4.  Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.

Authors:  Patrapim Sunpaweravong; Somkiat Sunpaweravong; Puttisak Puttawibul; Winyou Mitarnun; Chan Zeng; Anna E Barón; Wilbur Franklin; Sherif Said; Marileila Varella-Garcia
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-19       Impact factor: 4.553

5.  Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma.

Authors:  H Takeshita; D Ichikawa; S Komatsu; M Tsujiura; T Kosuga; K Deguchi; H Konishi; R Morimura; A Shiozaki; H Fujiwara; K Okamoto; E Otsuji
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

6.  Comparative genomic hybridization analysis of genetic aberrations associated with development of esophageal squamous cell carcinoma in Henan, China.

Authors:  Yan-Ru Qin; Li-Dong Wang; Zong-Min Fan; Dora Kwong; Xin-Yuan Guan
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

Review 7.  Genomic biomarkers for molecular imaging: predicting the future.

Authors:  Mathew L Thakur
Journal:  Semin Nucl Med       Date:  2009-07       Impact factor: 4.446

8.  Upregulation of SYF2 in esophageal squamous cell carcinoma promotes tumor cell proliferation and predicts poor prognosis.

Authors:  Junya Zhu; Lili Ji; Jianguo Zhang; Lei Yang; Chengqi Guan; Yayun Wang; Jia Zhu; Li Liang; Runzhou Ni
Journal:  Tumour Biol       Date:  2014-07-18

9.  Immunohistochemistry of cyclin D3 in pulmonary carcinomas.

Authors:  H Usuda; T Saito; I Emura; M Naito
Journal:  Virchows Arch       Date:  1996-06       Impact factor: 4.064

10.  Effects of Baneh (Pistacia atlantica) Gum on Human Breast Cancer Cell Line (MCF-7) and Its Interaction with Anticancer Drug Doxorubicin.

Authors:  Hamzeh Pasban-Aliabadi; Vahid Sobhani; Saeed Esmaeili-Mahani; Hamid Najafipour; Alireza Askari; Hamidreza Jalalian
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.